{"transactions":[{"id":1655571,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-07T18:00:11.000Z","date":"2024-02-05","kind":"exercise","planned":true,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 59,732 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":41732,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001415889-24-002957","document":"form4-02072024_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924002957/form4-02072024_060201.xml","form_type":"4"}},{"id":1655570,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-07T18:00:11.000Z","date":"2024-02-05","kind":"exercise","planned":true,"acquired":false,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 49,908 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":34908,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001415889-24-002957","document":"form4-02072024_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924002957/form4-02072024_060201.xml","form_type":"4"}},{"id":1655569,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-07T18:00:11.000Z","date":"2024-02-05","kind":"exercise","planned":true,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on May 2, 2021."}],"balance_after":10894,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001415889-24-002957","document":"form4-02072024_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924002957/form4-02072024_060201.xml","form_type":"4"}},{"id":1655568,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-07T18:00:11.000Z","date":"2024-02-05","kind":"exercise","planned":true,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 14,488 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on June 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":9088,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001415889-24-002957","document":"form4-02072024_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924002957/form4-02072024_060201.xml","form_type":"4"}},{"id":1655567,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-07T18:00:11.000Z","date":"2024-02-05","kind":"exercise","planned":true,"acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":13308,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0001415889-24-002957","document":"form4-02072024_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924002957/form4-02072024_060201.xml","form_type":"4"}},{"id":1655566,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-02-07T18:00:11.000Z","date":"2024-02-05","kind":"sale","planned":true,"acquired":false,"shares":4600,"price":17.4455,"value":80249.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.16 to $18.075, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1609,"source":{"system":"sec-edgar","filing":"0001415889-24-002957","document":"form4-02072024_060201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924002957/form4-02072024_060201.xml","form_type":"4"}},{"id":1655565,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-02-07T18:00:11.000Z","date":"2024-02-05","kind":"exercise","planned":true,"acquired":true,"shares":3200,"price":2.14,"value":6848.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."}],"balance_after":6209,"source":{"system":"sec-edgar","filing":"0001415889-24-002957","document":"form4-02072024_060201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924002957/form4-02072024_060201.xml","form_type":"4"}},{"id":1655564,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-02-07T18:00:11.000Z","date":"2024-02-05","kind":"exercise","planned":true,"acquired":true,"shares":1400,"price":1.74,"value":2436.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."}],"balance_after":3009,"source":{"system":"sec-edgar","filing":"0001415889-24-002957","document":"form4-02072024_060201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924002957/form4-02072024_060201.xml","form_type":"4"}},{"id":1672261,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-24T18:00:27.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":66586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on February 22, 2024."}],"balance_after":66586,"derivative":{"exercise_price":20,"expiration_date":"2034-01-21","underlying":"Common Stock","underlying_shares":66586},"source":{"system":"sec-edgar","filing":"0001415889-24-001775","document":"form4-01242024_060107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924001775/form4-01242024_060107.xml","form_type":"4"}},{"id":1684534,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-08T18:00:20.000Z","date":"2024-01-05","kind":"exercise","planned":true,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"A total of 59,732 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":43232,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001415889-24-000818","document":"form4-01082024_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924000818/form4-01082024_060101.xml","form_type":"4"}},{"id":1684533,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-08T18:00:20.000Z","date":"2024-01-05","kind":"exercise","planned":true,"acquired":false,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 49,908 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":36108,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001415889-24-000818","document":"form4-01082024_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924000818/form4-01082024_060101.xml","form_type":"4"}},{"id":1684532,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-08T18:00:20.000Z","date":"2024-01-05","kind":"exercise","planned":true,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on May 2, 2021."}],"balance_after":11394,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001415889-24-000818","document":"form4-01082024_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924000818/form4-01082024_060101.xml","form_type":"4"}},{"id":1684531,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-08T18:00:20.000Z","date":"2024-01-05","kind":"exercise","planned":true,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 14,488 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on June 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":9588,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001415889-24-000818","document":"form4-01082024_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924000818/form4-01082024_060101.xml","form_type":"4"}},{"id":1684530,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-08T18:00:20.000Z","date":"2024-01-05","kind":"exercise","planned":true,"acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":14208,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0001415889-24-000818","document":"form4-01082024_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924000818/form4-01082024_060101.xml","form_type":"4"}},{"id":1684529,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-01-08T18:00:20.000Z","date":"2024-01-05","kind":"sale","planned":true,"acquired":false,"shares":2474,"price":19.5718,"value":48420.6332,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.375 to $19.88, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request"}],"balance_after":1609,"source":{"system":"sec-edgar","filing":"0001415889-24-000818","document":"form4-01082024_060101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924000818/form4-01082024_060101.xml","form_type":"4"}},{"id":1684528,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-01-08T18:00:20.000Z","date":"2024-01-05","kind":"sale","planned":true,"acquired":false,"shares":2126,"price":18.6713,"value":39695.1838,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.315 to $19.30, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":4083,"source":{"system":"sec-edgar","filing":"0001415889-24-000818","document":"form4-01082024_060101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924000818/form4-01082024_060101.xml","form_type":"4"}},{"id":1684527,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-01-08T18:00:20.000Z","date":"2024-01-05","kind":"exercise","planned":true,"acquired":true,"shares":3200,"price":2.14,"value":6848.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."}],"balance_after":6209,"source":{"system":"sec-edgar","filing":"0001415889-24-000818","document":"form4-01082024_060101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924000818/form4-01082024_060101.xml","form_type":"4"}},{"id":1684526,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-01-08T18:00:20.000Z","date":"2024-01-05","kind":"exercise","planned":true,"acquired":true,"shares":1400,"price":1.74,"value":2436.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."}],"balance_after":3009,"source":{"system":"sec-edgar","filing":"0001415889-24-000818","document":"form4-01082024_060101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588924000818/form4-01082024_060101.xml","form_type":"4"}},{"id":1719253,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-07T18:00:15.000Z","date":"2023-12-05","kind":"exercise","planned":true,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 59,732 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":44732,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001415889-23-015987","document":"form4-12072023_061204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015987/form4-12072023_061204.xml","form_type":"4"}},{"id":1719252,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-07T18:00:15.000Z","date":"2023-12-05","kind":"exercise","planned":true,"acquired":false,"shares":1200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 49,908 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":37308,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1200},"source":{"system":"sec-edgar","filing":"0001415889-23-015987","document":"form4-12072023_061204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015987/form4-12072023_061204.xml","form_type":"4"}},{"id":1719251,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-07T18:00:15.000Z","date":"2023-12-05","kind":"exercise","planned":true,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on May 2, 2021."}],"balance_after":11894,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001415889-23-015987","document":"form4-12072023_061204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015987/form4-12072023_061204.xml","form_type":"4"}},{"id":1719250,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-07T18:00:15.000Z","date":"2023-12-05","kind":"exercise","planned":true,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 14,488 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on June 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":10088,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001415889-23-015987","document":"form4-12072023_061204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015987/form4-12072023_061204.xml","form_type":"4"}},{"id":1719249,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-07T18:00:15.000Z","date":"2023-12-05","kind":"exercise","planned":true,"acquired":false,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":15108,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":900},"source":{"system":"sec-edgar","filing":"0001415889-23-015987","document":"form4-12072023_061204.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015987/form4-12072023_061204.xml","form_type":"4"}},{"id":1719248,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-12-07T18:00:15.000Z","date":"2023-12-05","kind":"sale","planned":true,"acquired":false,"shares":4600,"price":16.3034,"value":74995.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.07 to $16.62, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1609,"source":{"system":"sec-edgar","filing":"0001415889-23-015987","document":"form4-12072023_061204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015987/form4-12072023_061204.xml","form_type":"4"}},{"id":1719247,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-12-07T18:00:15.000Z","date":"2023-12-05","kind":"exercise","planned":true,"acquired":true,"shares":3200,"price":2.14,"value":6848.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."}],"balance_after":6209,"source":{"system":"sec-edgar","filing":"0001415889-23-015987","document":"form4-12072023_061204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015987/form4-12072023_061204.xml","form_type":"4"}},{"id":1719246,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-12-07T18:00:15.000Z","date":"2023-12-05","kind":"exercise","planned":true,"acquired":true,"shares":1400,"price":1.74,"value":2436.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."}],"balance_after":3009,"source":{"system":"sec-edgar","filing":"0001415889-23-015987","document":"form4-12072023_061204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015987/form4-12072023_061204.xml","form_type":"4"}},{"id":1729703,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-27T18:00:17.000Z","date":"2023-11-22","kind":"exercise","planned":true,"acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 59,732 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":46232,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001415889-23-015508","document":"form4-11272023_061102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015508/form4-11272023_061102.xml","form_type":"4"}},{"id":1729702,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-27T18:00:17.000Z","date":"2023-11-22","kind":"exercise","planned":true,"acquired":false,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 49,908 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":38508,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":3600},"source":{"system":"sec-edgar","filing":"0001415889-23-015508","document":"form4-11272023_061102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015508/form4-11272023_061102.xml","form_type":"4"}},{"id":1729701,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-27T18:00:17.000Z","date":"2023-11-22","kind":"exercise","planned":true,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on May 2, 2021."}],"balance_after":12394,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001415889-23-015508","document":"form4-11272023_061102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015508/form4-11272023_061102.xml","form_type":"4"}},{"id":1729700,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-27T18:00:17.000Z","date":"2023-11-22","kind":"exercise","planned":true,"acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 14,488 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on June 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":10588,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001415889-23-015508","document":"form4-11272023_061102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015508/form4-11272023_061102.xml","form_type":"4"}},{"id":1729699,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-27T18:00:17.000Z","date":"2023-11-22","kind":"exercise","planned":true,"acquired":false,"shares":2700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":16008,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":2700},"source":{"system":"sec-edgar","filing":"0001415889-23-015508","document":"form4-11272023_061102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015508/form4-11272023_061102.xml","form_type":"4"}},{"id":1729698,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-11-27T18:00:17.000Z","date":"2023-11-22","kind":"sale","planned":true,"acquired":false,"shares":13800,"price":15,"value":207000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."}],"balance_after":1609,"source":{"system":"sec-edgar","filing":"0001415889-23-015508","document":"form4-11272023_061102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015508/form4-11272023_061102.xml","form_type":"4"}},{"id":1729697,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-11-27T18:00:17.000Z","date":"2023-11-22","kind":"exercise","planned":true,"acquired":true,"shares":9600,"price":2.14,"value":20544.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."}],"balance_after":15409,"source":{"system":"sec-edgar","filing":"0001415889-23-015508","document":"form4-11272023_061102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015508/form4-11272023_061102.xml","form_type":"4"}},{"id":1729696,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-11-27T18:00:17.000Z","date":"2023-11-22","kind":"exercise","planned":true,"acquired":true,"shares":4200,"price":1.74,"value":7308.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023."}],"balance_after":5809,"source":{"system":"sec-edgar","filing":"0001415889-23-015508","document":"form4-11272023_061102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923015508/form4-11272023_061102.xml","form_type":"4"}},{"id":1833100,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-07T18:00:06.000Z","date":"2023-07-05","kind":"exercise","planned":true,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"A total of 59,732 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":50732,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001415889-23-010965","document":"form4-07072023_060701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923010965/form4-07072023_060701.xml","form_type":"4"}},{"id":1833099,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-07T18:00:06.000Z","date":"2023-07-05","kind":"exercise","planned":true,"acquired":false,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 49,908 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":42108,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":650},"source":{"system":"sec-edgar","filing":"0001415889-23-010965","document":"form4-07072023_060701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923010965/form4-07072023_060701.xml","form_type":"4"}},{"id":1833098,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-07T18:00:06.000Z","date":"2023-07-05","kind":"exercise","planned":true,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on May 2, 2021."}],"balance_after":13894,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-23-010965","document":"form4-07072023_060701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923010965/form4-07072023_060701.xml","form_type":"4"}},{"id":1833097,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-07T18:00:06.000Z","date":"2023-07-05","kind":"exercise","planned":true,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 14,488 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on June 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":12088,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-23-010965","document":"form4-07072023_060701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923010965/form4-07072023_060701.xml","form_type":"4"}},{"id":1833096,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-07T18:00:06.000Z","date":"2023-07-05","kind":"exercise","planned":true,"acquired":false,"shares":450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":18708,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":450},"source":{"system":"sec-edgar","filing":"0001415889-23-010965","document":"form4-07072023_060701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923010965/form4-07072023_060701.xml","form_type":"4"}},{"id":1833095,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-07-07T18:00:06.000Z","date":"2023-07-05","kind":"sale","planned":true,"acquired":false,"shares":219,"price":17.8686,"value":3913.2234,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.84 to $18.17, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1609,"source":{"system":"sec-edgar","filing":"0001415889-23-010965","document":"form4-07072023_060701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923010965/form4-07072023_060701.xml","form_type":"4"}},{"id":1833094,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-07-07T18:00:06.000Z","date":"2023-07-05","kind":"sale","planned":true,"acquired":false,"shares":2031,"price":17.2337,"value":35001.6447,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.68 to $17.635, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1828,"source":{"system":"sec-edgar","filing":"0001415889-23-010965","document":"form4-07072023_060701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923010965/form4-07072023_060701.xml","form_type":"4"}},{"id":1833093,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-07-07T18:00:06.000Z","date":"2023-07-05","kind":"exercise","planned":true,"acquired":true,"shares":1600,"price":2.14,"value":3424.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."}],"balance_after":3859,"source":{"system":"sec-edgar","filing":"0001415889-23-010965","document":"form4-07072023_060701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923010965/form4-07072023_060701.xml","form_type":"4"}},{"id":1833092,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-07-07T18:00:06.000Z","date":"2023-07-05","kind":"exercise","planned":true,"acquired":true,"shares":650,"price":1.74,"value":1131.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."}],"balance_after":2259,"source":{"system":"sec-edgar","filing":"0001415889-23-010965","document":"form4-07072023_060701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923010965/form4-07072023_060701.xml","form_type":"4"}},{"id":1864197,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-07T18:00:09.000Z","date":"2023-06-05","kind":"exercise","planned":true,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 59,732 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":51482,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001415889-23-009390","document":"form4-06072023_060602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923009390/form4-06072023_060602.xml","form_type":"4"}},{"id":1864196,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-07T18:00:09.000Z","date":"2023-06-05","kind":"exercise","planned":true,"acquired":false,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 49,908 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":42758,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":650},"source":{"system":"sec-edgar","filing":"0001415889-23-009390","document":"form4-06072023_060602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923009390/form4-06072023_060602.xml","form_type":"4"}},{"id":1864195,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-07T18:00:09.000Z","date":"2023-06-05","kind":"exercise","planned":true,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on May 2, 2021."}],"balance_after":14094,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-23-009390","document":"form4-06072023_060602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923009390/form4-06072023_060602.xml","form_type":"4"}},{"id":1864194,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-07T18:00:09.000Z","date":"2023-06-05","kind":"exercise","planned":true,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 14,488 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on June 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":12288,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-23-009390","document":"form4-06072023_060602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923009390/form4-06072023_060602.xml","form_type":"4"}},{"id":1864193,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-07T18:00:09.000Z","date":"2023-06-05","kind":"exercise","planned":true,"acquired":false,"shares":450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":19158,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":450},"source":{"system":"sec-edgar","filing":"0001415889-23-009390","document":"form4-06072023_060602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923009390/form4-06072023_060602.xml","form_type":"4"}},{"id":1864192,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-06-07T18:00:09.000Z","date":"2023-06-05","kind":"sale","planned":true,"acquired":false,"shares":2250,"price":16.256,"value":36576.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.96 to $16.72, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1609,"source":{"system":"sec-edgar","filing":"0001415889-23-009390","document":"form4-06072023_060602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923009390/form4-06072023_060602.xml","form_type":"4"}},{"id":1864191,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-06-07T18:00:09.000Z","date":"2023-06-05","kind":"exercise","planned":true,"acquired":true,"shares":1600,"price":2.14,"value":3424.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."}],"balance_after":3859,"source":{"system":"sec-edgar","filing":"0001415889-23-009390","document":"form4-06072023_060602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923009390/form4-06072023_060602.xml","form_type":"4"}},{"id":1864190,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-06-07T18:00:09.000Z","date":"2023-06-05","kind":"exercise","planned":true,"acquired":true,"shares":650,"price":1.74,"value":1131.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."}],"balance_after":2259,"source":{"system":"sec-edgar","filing":"0001415889-23-009390","document":"form4-06072023_060602.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923009390/form4-06072023_060602.xml","form_type":"4"}},{"id":1899755,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T18:00:21.000Z","date":"2023-05-05","kind":"exercise","planned":true,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"A total of 59,732 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":52232,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001415889-23-007685","document":"form4-05092023_060501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923007685/form4-05092023_060501.xml","form_type":"4"}},{"id":1899754,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T18:00:21.000Z","date":"2023-05-05","kind":"exercise","planned":true,"acquired":false,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 49,908 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":43408,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":650},"source":{"system":"sec-edgar","filing":"0001415889-23-007685","document":"form4-05092023_060501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923007685/form4-05092023_060501.xml","form_type":"4"}},{"id":1899753,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T18:00:21.000Z","date":"2023-05-05","kind":"exercise","planned":true,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on May 2, 2021."}],"balance_after":14294,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-23-007685","document":"form4-05092023_060501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923007685/form4-05092023_060501.xml","form_type":"4"}},{"id":1899752,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T18:00:21.000Z","date":"2023-05-05","kind":"exercise","planned":true,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 14,488 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on June 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":12488,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-23-007685","document":"form4-05092023_060501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923007685/form4-05092023_060501.xml","form_type":"4"}},{"id":1899751,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-09T18:00:21.000Z","date":"2023-05-05","kind":"exercise","planned":true,"acquired":false,"shares":450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":19608,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":450},"source":{"system":"sec-edgar","filing":"0001415889-23-007685","document":"form4-05092023_060501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923007685/form4-05092023_060501.xml","form_type":"4"}},{"id":1899750,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-05-09T18:00:21.000Z","date":"2023-05-05","kind":"sale","planned":true,"acquired":false,"shares":205,"price":21.6348,"value":4435.134,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.225 to $21.805, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1609,"source":{"system":"sec-edgar","filing":"0001415889-23-007685","document":"form4-05092023_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923007685/form4-05092023_060501.xml","form_type":"4"}},{"id":1899749,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-05-09T18:00:21.000Z","date":"2023-05-05","kind":"sale","planned":true,"acquired":false,"shares":2045,"price":20.793,"value":42521.685,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.22 to $21.15, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1814,"source":{"system":"sec-edgar","filing":"0001415889-23-007685","document":"form4-05092023_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923007685/form4-05092023_060501.xml","form_type":"4"}},{"id":1899748,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-05-09T18:00:21.000Z","date":"2023-05-05","kind":"exercise","planned":true,"acquired":true,"shares":1600,"price":2.14,"value":3424.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."}],"balance_after":3859,"source":{"system":"sec-edgar","filing":"0001415889-23-007685","document":"form4-05092023_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923007685/form4-05092023_060501.xml","form_type":"4"}},{"id":1899747,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-05-09T18:00:21.000Z","date":"2023-05-05","kind":"exercise","planned":true,"acquired":true,"shares":650,"price":1.74,"value":1131.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."}],"balance_after":2259,"source":{"system":"sec-edgar","filing":"0001415889-23-007685","document":"form4-05092023_060501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923007685/form4-05092023_060501.xml","form_type":"4"}},{"id":1923133,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-07T18:00:09.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"A total of 59,732 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":52982,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001415889-23-006376","document":"form4-04072023_060401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923006376/form4-04072023_060401.xml","form_type":"4"}},{"id":1923132,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-07T18:00:09.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":false,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 49,908 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":44058,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":650},"source":{"system":"sec-edgar","filing":"0001415889-23-006376","document":"form4-04072023_060401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923006376/form4-04072023_060401.xml","form_type":"4"}},{"id":1923131,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-07T18:00:09.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on May 2, 2021."}],"balance_after":14494,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-23-006376","document":"form4-04072023_060401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923006376/form4-04072023_060401.xml","form_type":"4"}},{"id":1923130,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-07T18:00:09.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 14,488 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on June 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":12688,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-23-006376","document":"form4-04072023_060401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923006376/form4-04072023_060401.xml","form_type":"4"}},{"id":1923129,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-07T18:00:09.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":false,"shares":450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":20058,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":450},"source":{"system":"sec-edgar","filing":"0001415889-23-006376","document":"form4-04072023_060401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923006376/form4-04072023_060401.xml","form_type":"4"}},{"id":1923128,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-04-07T18:00:09.000Z","date":"2023-04-05","kind":"sale","planned":false,"acquired":false,"shares":535,"price":19.1056,"value":10221.496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.78 to $19.51, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1609,"source":{"system":"sec-edgar","filing":"0001415889-23-006376","document":"form4-04072023_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923006376/form4-04072023_060401.xml","form_type":"4"}},{"id":1923127,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-04-07T18:00:09.000Z","date":"2023-04-05","kind":"sale","planned":false,"acquired":false,"shares":1715,"price":17.913,"value":30720.795,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $17.63 to $18.45, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":2144,"source":{"system":"sec-edgar","filing":"0001415889-23-006376","document":"form4-04072023_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923006376/form4-04072023_060401.xml","form_type":"4"}},{"id":1923126,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-04-07T18:00:09.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":true,"shares":1600,"price":2.14,"value":3424.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."}],"balance_after":3859,"source":{"system":"sec-edgar","filing":"0001415889-23-006376","document":"form4-04072023_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923006376/form4-04072023_060401.xml","form_type":"4"}},{"id":1923125,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-04-07T18:00:09.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":true,"shares":650,"price":1.74,"value":1131.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."}],"balance_after":2259,"source":{"system":"sec-edgar","filing":"0001415889-23-006376","document":"form4-04072023_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923006376/form4-04072023_060401.xml","form_type":"4"}},{"id":1963738,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-08T18:00:17.000Z","date":"2023-03-06","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"A total of 59,732 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":53732,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001415889-23-004512","document":"form4-03082023_060305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923004512/form4-03082023_060305.xml","form_type":"4"}},{"id":1963737,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-08T18:00:17.000Z","date":"2023-03-06","kind":"exercise","acquired":false,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 49,908 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":44708,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":650},"source":{"system":"sec-edgar","filing":"0001415889-23-004512","document":"form4-03082023_060305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923004512/form4-03082023_060305.xml","form_type":"4"}},{"id":1963736,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-08T18:00:17.000Z","date":"2023-03-06","kind":"exercise","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on May 2, 2021."}],"balance_after":14694,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-23-004512","document":"form4-03082023_060305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923004512/form4-03082023_060305.xml","form_type":"4"}},{"id":1963735,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-08T18:00:17.000Z","date":"2023-03-06","kind":"exercise","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 14,488 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on June 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":12888,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-23-004512","document":"form4-03082023_060305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923004512/form4-03082023_060305.xml","form_type":"4"}},{"id":1963734,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-08T18:00:17.000Z","date":"2023-03-06","kind":"exercise","acquired":false,"shares":450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":20508,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":450},"source":{"system":"sec-edgar","filing":"0001415889-23-004512","document":"form4-03082023_060305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923004512/form4-03082023_060305.xml","form_type":"4"}},{"id":1963733,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-03-08T18:00:17.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":45,"price":24.924,"value":1121.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.755 to $24.96, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1609,"source":{"system":"sec-edgar","filing":"0001415889-23-004512","document":"form4-03082023_060305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923004512/form4-03082023_060305.xml","form_type":"4"}},{"id":1963732,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-03-08T18:00:17.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":2205,"price":23.727,"value":52318.035,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.445 to $24.38, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1654,"source":{"system":"sec-edgar","filing":"0001415889-23-004512","document":"form4-03082023_060305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923004512/form4-03082023_060305.xml","form_type":"4"}},{"id":1963731,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-03-08T18:00:17.000Z","date":"2023-03-06","kind":"exercise","acquired":true,"shares":1600,"price":2.14,"value":3424.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."}],"balance_after":3859,"source":{"system":"sec-edgar","filing":"0001415889-23-004512","document":"form4-03082023_060305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923004512/form4-03082023_060305.xml","form_type":"4"}},{"id":1963730,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-03-08T18:00:17.000Z","date":"2023-03-06","kind":"exercise","acquired":true,"shares":650,"price":1.74,"value":1131.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."}],"balance_after":2259,"source":{"system":"sec-edgar","filing":"0001415889-23-004512","document":"form4-03082023_060305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923004512/form4-03082023_060305.xml","form_type":"4"}},{"id":2026765,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-08T18:00:20.000Z","date":"2023-02-07","kind":"grant","acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on March 7, 2023."}],"balance_after":62000,"derivative":{"exercise_price":25.57,"expiration_date":"2033-02-06","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001415889-23-002169","document":"form4-02082023_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923002169/form4-02082023_060201.xml","form_type":"4"}},{"id":2026764,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-08T18:00:20.000Z","date":"2023-02-06","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 59,732 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":54482,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001415889-23-002169","document":"form4-02082023_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923002169/form4-02082023_060201.xml","form_type":"4"}},{"id":2026763,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-08T18:00:20.000Z","date":"2023-02-06","kind":"exercise","acquired":false,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 49,908 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":45358,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":650},"source":{"system":"sec-edgar","filing":"0001415889-23-002169","document":"form4-02082023_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923002169/form4-02082023_060201.xml","form_type":"4"}},{"id":2026762,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-08T18:00:20.000Z","date":"2023-02-06","kind":"exercise","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on May 2, 2021."}],"balance_after":14894,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-23-002169","document":"form4-02082023_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923002169/form4-02082023_060201.xml","form_type":"4"}},{"id":2026761,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-08T18:00:20.000Z","date":"2023-02-06","kind":"exercise","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 14,488 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on June 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":13088,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-23-002169","document":"form4-02082023_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923002169/form4-02082023_060201.xml","form_type":"4"}},{"id":2026760,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-08T18:00:20.000Z","date":"2023-02-06","kind":"exercise","acquired":false,"shares":450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":20958,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":450},"source":{"system":"sec-edgar","filing":"0001415889-23-002169","document":"form4-02082023_060201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923002169/form4-02082023_060201.xml","form_type":"4"}},{"id":2026759,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-02-08T18:00:20.000Z","date":"2023-02-06","kind":"sale","acquired":false,"shares":2250,"price":24.272,"value":54612.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.84 to $24.74, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1609,"source":{"system":"sec-edgar","filing":"0001415889-23-002169","document":"form4-02082023_060201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923002169/form4-02082023_060201.xml","form_type":"4"}},{"id":2026758,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-02-08T18:00:20.000Z","date":"2023-02-06","kind":"exercise","acquired":true,"shares":1600,"price":2.14,"value":3424.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."}],"balance_after":3859,"source":{"system":"sec-edgar","filing":"0001415889-23-002169","document":"form4-02082023_060201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923002169/form4-02082023_060201.xml","form_type":"4"}},{"id":2026757,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-02-08T18:00:20.000Z","date":"2023-02-06","kind":"exercise","acquired":true,"shares":650,"price":1.74,"value":1131.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."}],"balance_after":2259,"source":{"system":"sec-edgar","filing":"0001415889-23-002169","document":"form4-02082023_060201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923002169/form4-02082023_060201.xml","form_type":"4"}},{"id":2059101,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T18:00:22.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 59,732 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":55232,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001415889-23-000708","document":"form4-01092023_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923000708/form4-01092023_060101.xml","form_type":"4"}},{"id":2059100,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T18:00:22.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 49,908 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":46008,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":650},"source":{"system":"sec-edgar","filing":"0001415889-23-000708","document":"form4-01092023_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923000708/form4-01092023_060101.xml","form_type":"4"}},{"id":2059099,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T18:00:22.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on May 2, 2021."}],"balance_after":15094,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-23-000708","document":"form4-01092023_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923000708/form4-01092023_060101.xml","form_type":"4"}},{"id":2059098,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T18:00:22.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 14,488 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on June 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":13288,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-23-000708","document":"form4-01092023_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923000708/form4-01092023_060101.xml","form_type":"4"}},{"id":2059097,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-09T18:00:22.000Z","date":"2023-01-05","kind":"exercise","acquired":false,"shares":450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":21408,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":450},"source":{"system":"sec-edgar","filing":"0001415889-23-000708","document":"form4-01092023_060101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923000708/form4-01092023_060101.xml","form_type":"4"}},{"id":2059096,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-01-09T18:00:22.000Z","date":"2023-01-05","kind":"sale","acquired":false,"shares":2250,"price":26.402,"value":59404.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.21 to $26.74, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1609,"source":{"system":"sec-edgar","filing":"0001415889-23-000708","document":"form4-01092023_060101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923000708/form4-01092023_060101.xml","form_type":"4"}},{"id":2059095,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-01-09T18:00:22.000Z","date":"2023-01-05","kind":"exercise","acquired":true,"shares":1600,"price":2.14,"value":3424.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."}],"balance_after":3859,"source":{"system":"sec-edgar","filing":"0001415889-23-000708","document":"form4-01092023_060101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923000708/form4-01092023_060101.xml","form_type":"4"}},{"id":2059094,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-01-09T18:00:22.000Z","date":"2023-01-05","kind":"exercise","acquired":true,"shares":650,"price":1.74,"value":1131.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."}],"balance_after":2259,"source":{"system":"sec-edgar","filing":"0001415889-23-000708","document":"form4-01092023_060101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588923000708/form4-01092023_060101.xml","form_type":"4"}},{"id":2093548,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-07T18:00:10.000Z","date":"2022-12-05","kind":"exercise","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 59,732 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":55982,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001415889-22-012183","document":"form4-12072022_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588922012183/form4-12072022_061201.xml","form_type":"4"}},{"id":2093547,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-07T18:00:10.000Z","date":"2022-12-05","kind":"exercise","acquired":false,"shares":650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 49,908 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on July 4, 2021."}],"balance_after":46658,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":650},"source":{"system":"sec-edgar","filing":"0001415889-22-012183","document":"form4-12072022_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588922012183/form4-12072022_061201.xml","form_type":"4"}},{"id":2093546,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-07T18:00:10.000Z","date":"2022-12-05","kind":"exercise","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 16,294 shares subject to an employee stock option were granted on April 2, 2021, with options vesting in 48 equal monthly installments, with the first installment vested on May 2, 2021."}],"balance_after":15294,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-22-012183","document":"form4-12072022_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588922012183/form4-12072022_061201.xml","form_type":"4"}},{"id":2093545,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-07T18:00:10.000Z","date":"2022-12-05","kind":"exercise","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 14,488 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on June 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":13488,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":200},"source":{"system":"sec-edgar","filing":"0001415889-22-012183","document":"form4-12072022_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588922012183/form4-12072022_061201.xml","form_type":"4"}},{"id":2093544,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":94556,"kind":"person","name":"NIVEN RALPH","position":1,"cik":"0001168060","reported_name":"NIVEN RALPH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-07T18:00:10.000Z","date":"2022-12-05","kind":"exercise","acquired":false,"shares":450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 6, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of this option vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":21858,"derivative":{"exercise_price":1.74,"expiration_date":"2030-09-03","underlying":"Common Stock","underlying_shares":450},"source":{"system":"sec-edgar","filing":"0001415889-22-012183","document":"form4-12072022_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1168060/000141588922012183/form4-12072022_061201.xml","form_type":"4"}}],"next_cursor":"2022-12-07T18:00:10.000000Z,2093544"}